IVERIC bio (ISEE) Tops Q4 EPS by 53c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. BA
5. STX
6. V
7. CSGP
8. LSTR
9. UPS
10. KIDS

Go back to IVERIC bio (ISEE) Tops Q4 EPS by 53c

Iveric Bio Reports Fourth Quarter and Year End 2020 Operational Highlights and Financial Results

March 3, 2021 6:30 AM EST

- Patient Enrollment for GATHER2 Clinical Trial of Zimura® for the Treatment of Geographic Atrophy Secondary to Age-related Macular Degeneration Ahead of Target and Progressing Well; Completion of Enrollment Expected in 3Q of this Year -

- Conference Call and Webcast Today, March 3, 2021, at 8:00 a.m. ET -

NEW YORK--(BUSINESS WIRE)-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial and operating results for the fourth quarter and full year ended December 31, 2020 and provided a general business update.

The Company also announced that patient... More